Sunday, February 22, 2015 1:04:02 PM
I don't consider all biosimilar companies better than Momenta. I do consider many other the larger companies as being much better equipped and staffed to make Momenta a also ran at best. Get real, do you think Momenta could compete against the likes of Pfizer, Novartis, Amgen, Biogen etc?
They aren't even in the same ballpark.
Let me ask you a question, why did Sandoz limit their deal with Momenta to two drugs and Baxter to one drug? Why did it take Momenta forever to even strike a deal with Baxter while all the big boys inked many deals with others?
Momenta's future if it's going to succeed is in discovery, not copying.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM